Phreesia and New Jersey Urology Partner to Standardize Intake and Improve Patient Experience
March 30 2021 - 8:30AM
Business Wire
Phreesia is pleased to announce it has partnered with New Jersey
Urology (NJU), New Jersey’s largest urology services provider, to
standardize the patient intake process across NJU’s more than 60
locations, increasing efficiency, improving clinical care and
providing an engaging, convenient patient experience.
NJU also leverages Phreesia’s Dashboard embedded within Epic’s
Department Appointments Report (DAR), allowing staff to see and
respond to Phreesia’s notifications regarding payment and pre-visit
activities without leaving Epic’s interface.
“With the integration of Phreesia, NJU’s patient intake
landscape has completely changed,” said Derek Grimes, NJU’s Chief
Information Officer. “Mobile technology and personal devices are
the future of medicine, and the days of tethered technology are
quickly becoming a practice of the past. This pendulum swing
benefits all and, most importantly, it greatly supports the needs
and wants of our patients.”
In an effort to standardize their systems, NJU transitioned to
Epic’s EMR and Phreesia’s patient intake platform across all of
their urology and urologic oncology practices in October 2020.
NJU implemented a range of Phreesia’s intake applications
including Zero-Contact Intake, which supports no-waiting-room
workflows, allowing for at-home or car check-in. The tool
facilitates real-time text messages between the patient and staff
to coordinate arrival and minimize in-person exposure, creating a
safer intake process during the COVID-19 pandemic.
NJU also employs Phreesia to capture condition-specific clinical
data such as medical and surgical history. Based on patient
history, NJU leverages five different patient-reported outcome
measures to screen patients on their urological health: the Sexual
Health Inventory for Men, the Interstitial Cystitis Symptom Index,
the AUA symptom score to screen for enlarged prostate, and a
Urinary and Bladder Health questionnaire, along with a PHQ-2/9
depression screener. All data captured on Phreesia integrates into
Epic, saving clinical staff time and enabling more patient-focused
care.
During the 120 days since go-live:
- More than 40,600 patients completed urology-specific
patient-reported outcomes
- 54% of patients completed self-service registration before
their visit
- 84% of copays were paid at the time of service, and more than
12,000 cards were put on file
- 87% of patients rated their Phreesia check-in experience
favorably
“We’re honored to support NJU in their efforts to provide a
consistent and positive patient experience,” said Phreesia CEO
Chaim Indig. “We’re happy that our robust integration with Epic
enables practices to have a more streamlined workflow, and we’re
committed to collaborating with the organization over time to meet
their needs.”
About Phreesia
Phreesia gives healthcare organizations a suite of robust
applications to manage the patient intake process. Our innovative
SaaS platform engages patients in their healthcare and provides a
safe, convenient experience, while enabling our clients to enhance
clinical care and drive efficiency.
About New Jersey Urology
New Jersey Urology (NJU) is one of the largest urology groups in
the nation. NJU provides complete urologic care and individualized
treatment plans at more than 60 locations across New Jersey and
Eastern Pennsylvania, including six state-of-the-art Cancer
Treatment Centers. Utilizing the most advanced technologies and
techniques in the industry, NJU offers accurate precision
diagnosis, cutting-edge treatment options, and compassionate,
personalized care.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210330005252/en/
Annie Harris aharris@phreesia.com 929-526-2611
Kathy Meyer kmeyer@njurology.com 973-453-5652
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Jul 2023 to Jul 2024